Depth is expected in structural and clinical regulation (CPOM and fee-splitting, MSA design and fair market value, professional entity governance, state MSO transparency and transaction notice laws, medical board authority, scope of practice, credentialing and peer review, telehealth practice standards, informed consent, and licensure compacts) and in telehealth operations and data (Ryan Haight and DEA prescribing, PDMP and e-prescribing, pharmacy and compounding, HIPAA, 42 C.F.R. Part 2, state consumer health data and privacy laws, FTC Act Section 5, tracking technology, TCPA, and AI governance). We have no current government reimbursement, but working literacy in fraud and abuse — AKS, Stark, EKRA, CMP, False Claims Act, OIG guidance, and exclusion screening, is helpful.